As of September 2020, there are approximately 1800 pharma companies. The total value of global pharma sector has tripled in the last 17 years from $1.99 in 2003 to $6.65 trillion in 2020. The industry value CAGR since 2003 has been 7.4%.
Evolution of the pharma sector suggests Big Pharma sector grew slowly between 2015 to 2020, losing 5% in value share. In contrast, animal health and biotech sectors grew substantially in the same period.
In terms of specific drug modality, Biologics companies grew as a group by $1.1 trillion in just 5 years. Other big growth areas were vaccines, nucleic acids, peptides, cell therapy and gene therapy.
Considering country level evolution of Pharma industry, most countries have seen a rise, but none has seen an increase more than China which added over $500 billion in value over the last five years. In U.S. there has been an increase if 22% in the last five years.
The bar to be in the Pharma 1000 list has moved up gradually over time though. A company would need to have had a valuation of at least $336 million to be in the top 1000.
See the full list of Top 1000 Pharmaceutical Companies below.
Get the full report for FREE
- The Global Pharmaceutical Industry
- Rapid Growth of Biotech Sector
- The Evolving Branded Pharma Sector
- The Generic Pharma Sector
- Top 1000 Companies by Value
- Profiles of the Top 500 Companies
List of Top 1000 Pharmaceutical Companies by Value